ABSTRACT
INTRODUCTION
The use of fetal magnetic resonance imaging (MRI) is increasing in clinical practice, primarily to investigate abnormalities of the fetal brain suspected on antenatal ultrasound. Its use is likely to increase further following the publication of the results of the 'Magnetic resonance imaging to enhance the diagnosis of fetal developmental brain abnormalities in utero' (MERIDIAN) study 1 . MERIDIAN was a large prospective multicenter study allowing recruitment of all types of brain abnormalities recognized on ultrasound and showed an overall improvement in diagnostic accuracy of over 22% following inclusion of magnetic resonance imaging (MRI) in the diagnostic pathway. The MERIDIAN researchers enlisted the assistance of fetal medicine focus groups at the planning stage of the study and one recommendation was to perform subgroup analyses of fetuses with specific brain abnormalities. Failed commissuration (agenesis of the corpus callosum (CC) and hypogenesis of the CC) was considered to be an important group in terms of both number of cases and the widely held view of fetal-maternal experts that ultrasound performs well in detecting those pathologies. If that were found to be correct it would be difficult to justify the use of MRI based on the extra expense incurred and discomfort to the pregnant women.
The original MERIDIAN report gave a synoptic overview of the diagnostic performance in this subgroup 1 but a more detailed description is warranted because of the complexity of the cases. In this paper we describe the performance of MRI in characterizing brain abnormalities in fetuses with failed commissuration as the only finding suspected on ultrasound. Specifically, data are presented on diagnostic accuracy, diagnostic confidence and change in prognosis/clinical management brought about by including MRI in the diagnostic pathway.
METHODS
All cases reported in this paper were recruited into the MERIDIAN study; the overarching methodology of the MERIDIAN study is reported elsewhere 1 , but the parts relevant to this paper are summarized here. The MERIDIAN study was undertaken in accordance with the Medicines for Human Use (Clinical Trials) Regulations 2004 and ethics approval was obtained for a multicenter study through the Integrated Research Application System (62734). Recruitment was conducted from 16 fetal medicine units in the UK and inclusion criteria for the main study were pregnant women aged 16 years or over with a fetus with brain abnormality detected on ultrasound at a gestational age of 18 weeks or more, who had no contraindication to MRI and who were willing to provide written, fully informed consent to enter the study. This subgroup analysis describes those fetuses with either agenesis or hypogenesis of the CC as the only brain abnormality found on ultrasound, either with or without associated ventriculomegaly (VM).
Antenatal imaging with ultrasound and fetal MRI
All ultrasound studies were performed by appropriately trained NHS fetal medicine consultants and each brain abnormality was listed using nomenclature from the ViewPoint antenatal ultrasound reporting software (GE Healthcare, Chalfont St Giles, UK), along with an assessment of certainty of diagnosis for each brain abnormality using a five-point Likert scale 2 . All MRI examinations were performed on 1.5-T superconducting clinical systems at one of six centers. The base requirement for the MRI assessment was to obtain T2-weighted images of the fetal brain in the three orthogonal planes and a T1-weighted ultrafast sequence in at least one plane (usually axial). The reporting radiologist was aware of the diagnosis and the level of certainty made on ultrasound from the study paperwork and also had access to the full clinical ultrasound report. The radiologist was required to comment on each brain abnormality recognized on ultrasound (using 'diagnosis excluded' if the finding was not present on MRI) and add extra anatomical diagnoses, where appropriate, using a similar form to the one used for ultrasound. Each entry was accompanied by an indicator of confidence using the same Likert scale as in the ultrasound assessment.
Outcome reference data and assessment of diagnostic accuracy
In cases in which the pregnancy continued and the child survived, outcome reference data (ORD) were obtained from the clinical notes based on diagnoses made on postnatal neuroimaging studies up to the age of 6 months. In cases of termination of pregnancy, stillbirth or neonatal death, the ORD were based on autopsy and/or postmortem MRI. An independent pediatric neuroradiologist determined whether a full review of ORD by a multidisciplinary independent expert panel was required. Full review was required in every case unless there was complete and unequivocal agreement between the anatomical findings on ultrasound, MRI and the ORD. The multidisciplinary independent expert panel consisted of three NHS consultants (a neuroradiologist, fetal medicine consultant and pediatric neurologist) from a center that did not recruit into MERIDIAN and they were asked to judge whether the ultrasound-based and MRI-based diagnoses had complete agreement with the ORD. The primary analysis in the MERIDIAN study focused on participants who underwent MRI within 14 days of ultrasound and for whom ORD were available and consisted of a calculation of diagnostic accuracy for ultrasound and MRI studies defined as: (true positives + true negatives)/total number of cases. In this context, we defined the first group 'isolated failed commissuration' as ultrasound diagnosis of either agenesis or hypogenesis of the CC as the only brain abnormality (with or without VM), i.e. correctness was judged only by the presence of either CC abnormality and the absence of another brain lesion. The two subsequent analyses targeted the CC diagnoses directly by requiring the specific diagnoses 'agenesis of the CC' or 'hypogenesis of the CC' to be correct when compared with ORD, ignoring the presence of any other brain lesion. Diagnostic accuracy was calculated for ultrasound and MRI and compared using McNemar's test.
Assessment of diagnostic confidence
In line with the report of the whole cohort, the first analysis of diagnostic confidence simply describes the proportion of ultrasound and MRI diagnoses made with high and low confidence that were either correct or incorrect. 'High confidence' diagnosis was defined as 70% or 90% certainty and low confidence diagnosis as 10%, 30% or 50% certainty for this analysis.
Our previous publication describes the significant limitations of the conventional assessments of diagnostic confidence 1 , even if the Omary correction 3 is used. The major limitation occurs because those methods do not require confirmation that the diagnoses are either correct or incorrect (i.e. no ORD are required). All of the cases in this study have ORD and we have chosen to use the 'score-based weighted average' method described by Ng and Palmer 4 as our preferred method of describing appropriate diagnostic confidence. As highlighted in our previous publication 5 , this approach uses not only diagnostic confidence assessment but also indicators of diagnostic accuracy as provided by the multidisciplinary independent expert panel, specifically the following: was the overall diagnosis correct for MRI? Was the overall diagnosis correct for ultrasound? Which imaging method described the most severe pathology? This aspect was combined with a binary assessment of diagnostic confidence as either 'high' or 'low' as described above. An algorithm modified from Ng and Palmer 4 ( Figure S1 ) was used to define a route label for each case and hence derive a route score ranging from −4 to +4. Zero indicated no change in 'appropriate' confidence, whilst positive values indicated a benefit arising from the introduction of MRI and negative values that MRI had a detrimental effect on analysis, the larger the number the greater being the effect. For example, if ultrasound described agenesis of the CC as the only intracranial abnormality with high confidence but MRI excluded this diagnosis with high confidence, the score-based weighted average result would depend on the ORD. If agenesis of the CC was excluded on ORD, the route label would be A3 with a route score + 3, which indicates improved diagnostic impact of MRI, whereas if ORD confirmed agenesis of the CC, the route label would be F5 with a route score −4, which indicates a detrimental impact for MRI. The integer scores for all cases were plotted as a histogram and described in terms of the number of cases in which MRI reported with greater confidence (positive scores) and with reduced confidence (negative scores). The mean, SD and 95% CI were calculated and one sample t-tests were carried out to determine if the calculated scores differed from zero.
Assessment of effects on prognosis and clinical management
The MERIDIAN study collected data from the fetal medicine specialists about any changes in clinical management brought about by MRI, as described in detail elsewhere 1 ; in short, the specialists were asked to report whether MRI provided additional diagnostic information and whether it led to a change in the prognosis or management (including offering termination of pregnancy; TOP) of the case.
With respect to analysis of prognostic information, the fetal medicine experts were asked to report the prognostic information given to the woman based on the ultrasound scan results (but before MRI) using the following five categories: normal (no worse than the risk to a fetus without a demonstrable brain abnormality), favorable (normal neurological outcome expected in >90% of cases), intermediate (normal neurological outcome expected in 50-90% of cases), poor (normal neurological outcome expected in <50% of cases) and unknown.
At the next consultation with the woman, at which time the MRI report was available, the clinician recorded the updated prognostic information using the same five categories. For the purposes of this report we describe whether the prognosis remained the same, worsened or improved after MRI. This approach was straightforward when the prognosis was normal, favorable, intermediate or poor, and if the prognosis was unknown on both ultrasound and MRI. However, the decision was complicated when the prognosis on one imaging method was unknown but was specified on the other. In such cases, we made the following assignations:
• ultrasound prognosis 'Unknown', MRI prognosis 'Normal' or 'Favorable' = improved prognosis • ultrasound prognosis 'Unknown', MRI prognosis 'Intermediate' = no change in prognosis • ultrasound prognosis 'Unknown', MRI prognosis 'Poor' = worse prognosis • ultrasound prognosis 'Normal' or 'Favorable', MRI prognosis 'Unknown' = worse prognosis • ultrasound prognosis 'Intermediate', MRI prognosis 'Unknown' = no change in prognosis • ultrasound prognosis 'Poor', MRI prognosis 'Unknown' = no change in prognosis
If TOP was offered, clinicians were asked to report whether abnormalities seen on ultrasound only were sufficient to consider that option under Ground E of the Abortion Act 1967 (section 1(1)(d), 'substantial risk of serious mental or physical handicap') 6 and whether this decision was still valid after the MRI information was available.
RESULTS
Failed commissuration featured as a diagnosis on ultrasound in 92/570 (16.1%) fetuses from the main MERIDIAN cohort. Of these, 13 were excluded due to the presence of additional conditions other than VM, leaving 79 cases (13.9%) included in this study. Fifty-four of the cases had associated VM, and in 51 the MRI study was performed when the fetus was 18-23 weeks' gestational age. Hypogenesis of the CC was the specific diagnosis on ultrasound in 24/79 fetuses and agenesis of the CC in 55/79.
Diagnostic accuracy
A comparison of the findings on ultrasound and MRI in relation to ORD is shown in Table 1 . When 'isolated failed commissuration' was assessed as a group, the diagnostic accuracy of ultrasound was 34.2% compared with 94.9% Table 2 and representative cases are shown in Figures 1,  2 , S2 and S3. Cortical formation abnormalities were found in 10/12 fetuses, an absent septum pellucidum in one fetus and a parenchymal posterior fossa abnormality in one fetus. The overall diagnostic accuracy of ultrasound and MRI in diagnosing hypogenesis or agenesis of the CC correctly as discrete entities (irrespective of the presence of other brain abnormalities) is presented in Table 1 and the nature of the errors is shown in Table 3 . The diagnostic accuracy for detecting hypogenesis of the CC as a discrete entity was 8.3% on ultrasound and 87.5% on MRI (difference = 79.2%, 95% CI 55.1-100%, P < 0.0001) and the diagnostic accuracy for detecting agenesis of the CC as a distinct entity was 40.0% for ultrasound and 92.7% for MRI (difference = 52.7%, 95% CI 37.7-67.7%, P < 0.0001). The diagnosis of hypogenesis based on ultrasound was correct in 2/24 (8.3%) fetuses; ORD showed a normal CC in 20/24 fetuses and agenesis of the CC in 2/24. The diagnosis of agenesis of the CC based on ultrasound was confirmed by ORD in 22/55 (40.0%) cases, while 7/55 cases were hypogenesis of the CC and in 26/55 the CC was normal on ORD. CC was thought to be normal in 45/79 fetuses on MRI of which 43 (95.6%) were correct; the other two fetuses had hypogenesis of the CC. A diagnosis of hypogenesis of the CC was made on MRI in 8/79 fetuses and was correct in 6/8 cases (75%), whilst the diagnosis of agenesis of CC made on MRI was correct in 23/26 fetuses (88.5%).
Diagnostic confidence
The proportions of correct and incorrect diagnoses made with high and low diagnostic confidence are presented in Figure 3 . High confidence diagnoses were made in 29/79 (36.7%) fetuses on ultrasound and 76/79 (96.2%) fetuses on MRI, an increase of just under 60% of all cases. On ultrasound 13/29 (44.8%) high confidence diagnoses were incorrect in comparison with ORD, whilst on MRI 5/76 (6.6%) high confidence diagnoses were Figure 3 High (rated as 70% or 90%) and low (rated as 10%, 30% or 50%) confidence diagnoses made on ultrasound (US) and magnetic resonance imaging (MRI). Shaded parts of bars indicate number of diagnoses that were incorrect, and unshaded parts indicate those that were correct, in comparison with outcome reference data.
incorrect indicating >6-times reduction of high confidence but incorrect diagnoses by MRI when compared with ultrasound. On ultrasound 16/50 (32.0%) low confidence diagnoses were correct, whilst on MRI all three low confidence diagnoses were correct (100%). Diagnostic accuracy data were combined with diagnostic confidence data in order to calculate a 'score-based weighted average' impact of (appropriate) diagnostic confidence as shown in Figure 4 . The overall mean difference was +1.51 (95% CI, +1.14 to +1.87, P < 0.0001). In 60/79 the score was positive indicating an 'appropriate' improvement in diagnostic performance, 11/79 (14%) cases had a score of 0 (i.e. no effect) and the score was negative in 8/79 (10%) cases indicating a deleterious effect.
Prognosis and clinical management
The MRI studies provided extra diagnostic information compared with ultrasound in 50/79 (63.3%) fetuses according to the referring fetal maternal consultants. Prognostic information given to the women of the MRI study changed in 36/79 (45.6%) cases and in 20 fetuses the prognosis was worse after MRI. This included all 10 fetuses with cortical formation abnormalities as additional brain abnormalities, although the one case of absence of the cavum septi pellucidi did not have any effect on prognosis. In 16 fetuses the prognosis was improved after MRI (including 14 cases with 'normal' or 'favorable' prognostic categories). TOP was offered to women on the basis of the ultrasound findings alone in 26/79 (32.9%) cases and this increased to 39/79 (49.4%) after MRI. In 21 cases TOP was offered both before and after MRI and in five cases the offer was revoked because of a normal MRI (and confirmed on ORD). TOP was offered after MRI and not on the basis of ultrasound in 18 cases, which included nine fetuses with other brain malformations (all cortical formation abnormalities). The effect of MRI on the final choice of clinical management was considered to be of no influence in eight of the 79 cases, minor influence in 36, significant influence in 24, major influence in six and decisive influence in five cases.
Cases of failed commissuration identified on ORD
Agenesis or hypogenesis of the CC featured as a diagnosis on ORD in 76/570 (13.3%) cases and 35/76 (46.1%) of those were not diagnosed on ultrasound. In 23 fetuses the CC abnormality on ORD was the only intracranial abnormality (except VM), and hence other brain abnormalities were found in 53/76 (69.7%) cases of failed commissuration. Cortical formation and posterior fossa malformations featured highly amongst the other brain abnormalities.
DISCUSSION
The CC is the largest commissural structure in the human brain and as such is responsible for the majority of the connections between homologous areas of the cerebral hemispheres. Failure of the CC to form can either be complete (agenesis of the CC) or partial (hypogenesis of the CC) 7 and failure of commissuration is a term that is often used to include both entities. This study involved the 79 cases of the primary MERIDIAN cohort in which the abnormal CC was the only intracranial abnormality and was designed to look for improvements in diagnostic impact (diagnostic accuracy and diagnostic confidence) and changes in prognosis/clinical management by including MRI in the clinical pathway.
Expert focus groups interviewed before the start of MERIDIAN recommended subgroup analysis in the three commonest fetal brain abnormalities detected on antenatal ultrasound and the results of the VM 8 and posterior fossa 9 analyses are reported elsewhere. There are several reasons why the 'isolated failed commissuration' subgroup warrants specific study. It was the third commonest referral for MRI in the MERIDIAN study (nearly 14% of all cases) and there is a general perception among fetal medicine consultants that detection of agenesis of the CC with ultrasound is relatively straightforward, although it is accepted that detection of hypogenesis of the CC is more difficult. It should be noted that agenesis of the CC was diagnosed on ultrasound more than twice as often compared with hypogenesis of the CC in this study. There was, however, accumulating evidence from MRI studies before the start of the MERIDIAN study suggesting that the diagnosis of agenesis of the CC on ultrasound may not be straightforward. Most publications comparing ultrasound and MRI of the fetal brain from that period described CC pathology as the greatest source of discrepancy between ultrasound and MRI reports and this has been highlighted in systematic reviews and meta-analyses [10] [11] [12] [13] . In addition, a recent publication from our group based on the experience of 7 years of MRI studies immediately before the start of the MERIDIAN study raised serious questions about the ability of ultrasound to diagnose failed commissuration 14 . That study reported 121 fetuses with agenesis of the CC diagnosed on ultrasound and showed that the diagnosis on ultrasound was correct in fewer than 50% of cases (positive predictive value 47% (95% CI, 38-56%)). A serious weakness of that study was the lack of ORD in all cases and the results of MRI were taken as a surrogate reference standard. The major advantage of the current work is having ORD and the results confirm the concerns raised in the earlier papers. The diagnostic accuracy of ultrasound was 34.2% for 'isolated failed commissuration', and 8.3% for hypogenesis and 40% for agenesis of the CC as specific diagnoses. MRI increased the diagnostic accuracy by approximately 61%, 79% and 53%, respectively. It is important to note from Table 3 , however, that 6/7 of the errors made by MRI in this paper were related to the diagnosis of hypogenesis of the CC. This is a topic for further MRI development and research and the use of 3D MRI is showing progress in this area 15 . Every indicator of diagnostic confidence in this group points to further improvements in diagnostic impact when MRI is used. So, although the use of 3D ultrasound and post hoc reconstructions are reported to improve visualization of the CC, we must conclude from our data that MRI is imperative for the accurate diagnosis of CC abnormalities in utero 15 .
A further discussion point amongst the expert focus groups concerned the clinical significance of the diagnosis of agenesis/hypogenesis of the CC made in utero and some argued that it is not particularly important if the diagnosis is missed. This was considered to be true only when the CC abnormality was an isolated finding because of the relatively low risk of neurodevelopmental problems in children. There are several publications to support this view and many clinicians quote a 70-80% chance of good clinical outcome in these cases 16, 17 . Other studies, however, add the rider that the 'isolated' descriptor needs to be confirmed by MRI 18, 19 . The results of our current prospective study suggest that fetal-maternal experts in the UK consider agenesis and hypogenesis of the CC to be a clinically significant abnormality on two grounds. Firstly, nearly one third of the women reported in this study were offered TOP on the basis of the ultrasound findings. This point is underlined by the observation that, in the five cases in which MRI did not confirm a CC abnormality (or other brain abnormality), the decision to offer TOP was reversed. On this level alone, MRI is important in reducing the unnecessary worry for pregnant women and the risk of inappropriate TOP. Secondly, the high rate of other brain pathologies subsequently identified by MRI and confirmed on ORD (nearly 14%) usually led to worse prognoses being given. In 9/12 such cases, TOP was offered after MRI but not on the basis of ultrasound results alone. As shown in the entire MERIDIAN cohort, agenesis or hypogenesis of the CC was found on ORD in 76/570 cases, and in 46% the diagnosis was not made on ultrasound and other brain abnormalities were found in nearly 70%. It is not surprising, therefore, that fetal medicine consultants considered the overall effect of MRI on clinical management to be 'significant', 'major' or 'decisive' in over 44% of cases.
In conclusion, we have shown that ultrasound has low diagnostic accuracy for abnormalities of the CC and the majority of the errors made on ultrasound can be corrected by using MRI. Our data suggest that a woman whose fetus has failed commissuration as the only intracranial finding on ultrasound should have MRI for further evaluation.
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